ABM-2752

N/A

Report date: 2025/01/26 18:24:10
NME

Base Information

Drug NameABM-2752
Drug Alias NameHPK1 inhibitor (ABM Therapeutics)ABM-2752
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 1 inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 1
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsMelanoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesABM Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesABM Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsMelanoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A